All Stories

  1. Prognostic and predictive molecular biomarkers in metastatic renal cell carcinoma patients treated with immune checkpoint inhibitors: a systematic review

    Article • Expert Review of Molecular Diagnostics, October 2019, Taylor & Francis

    Sara Elena Rebuzzi, Melissa Bersanelli, Dr Sebastiano Buti

  2. Immunotherapy beyond progression in advanced renal cell carcinoma: a case report and review of the literature

    Article • Immunotherapy, September 2018, Future Medicine

    Sara Elena Rebuzzi, Dr Sebastiano Buti